# Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components (Text with EEA relevance), Division: Duration of deferral period

Extent: E+W+S+N.I.

After an infectious illness, prospective donors shall be deferred for at least two weeks following the date of full clinical recovery.
However, the following deferral periods shall apply for the infections listed in the table:
Brucellosis (*)
2 years following the date of full recovery
Osteomyelitis
2 years after confirmed cured
Q fever (*)
2 years following the date of confirmed cured
Syphilis (*)
1 year following the date of confirmed cured
Toxoplasmosis (*)
6 months following the date of clinical recovery
Tuberculosis
2 years following the date of confirmed cured
Rheumatic fever
2 years following the date of cessation of symptoms, unless evidence of chronic heart disease
Fever > °C
2 weeks following the date of cessation of symptoms
Flu-like illness
2 weeks after cessation of symptoms
Malaria (*)
—
individuals who have lived in a malarial area within the first five years of life
3 years following return from last visit to any endemic area, provided person remains symptom free;
may be reduced to 4 months if an immunologic or molecular genomic test is negative at each donation
—
individuals with a history of malaria
3 years following cessation of treatment and absence of symptoms.
Accept thereafter only if an immunologic or molecular genomic test is negative
—
asymptomatic visitors to endemic areas
6 months after leaving the endemic area unless an immunologic or molecular genomic test is negative
—
individuals with a history of undiagnosed febrile illness during or within six months of a visit to an endemic area
3 years following resolution of symptoms;
may be reduced to 4 months if an immunologic or molecular test is negative
West Nile Virus (WNV) (*)
28 days after leaving a risk area of locally acquired West Nile Virus unless an individual Nucleic Acid Test (NAT) is negative

---
Source: https://www.legislation.gov.uk/eudr/2004/33/annex/III/division/2/division/2.2/division/2.2.1/division/1 (the official version)
Page: https://openlegislation.uk/eu-directive-2004-33/annex-III/division-2/division-2.2/division-2.2.1/division-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.